United States securities and exchange commission logo





                              June 15, 2022

       Danny Yeung
       Chief Executive Officer
       Prenetics Global Limited
       Unit 701-706, K11 Atelier King   s Road 728 King   s Road, Quarry Bay
       Hong Kong

                                                        Re: Prenetics Global
Limited
                                                            Amendment No. 1 to
Registration Statement on Form F-1
                                                            Filed June 10, 2022
                                                            File No. 333-265284

       Dear Mr. Yeung:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.

       Amendment No. 1 to Registration Statement on Form F-1

       Frequently Used Terms, page viii

   1.                                                   Please revise the
definition of "China" and "PRC" to include Hong Kong and Macau.
       Risk Factors
       You may face difficulties in protecting your interests, and your ability
to protect your rights
       through U.S. courts..., page 57

   2.                                                   Please revise the
disclosure in this risk factor to include where your executive officers and
                                                        directors are located.
To the extent these individuals are located in China (including Hong
                                                        Kong and Macau), please
address the difficulty of bringing actions against individuals
                                                        located in China and
enforcing judgments against them. In addition, to the extent any of
                                                        your officers or
directors are located in China, please include Summary Risk Factor
 Danny Yeung
Prenetics Global Limited
June 15, 2022
Page 2
      disclosure indicating that it may be difficult to enforce any judgments
obtained from
      foreign courts against the company or the company   s officers and
directors in China.
       Please contact Alan Campbell at 202-551-4224 or Laura Crotty at
202-551-7614 with
any questions.



                                                           Sincerely,
FirstName LastNameDanny Yeung
                                                           Division of
Corporation Finance
Comapany NamePrenetics Global Limited
                                                           Office of Life
Sciences
June 15, 2022 Page 2
cc:       Jonathan B. Stone, Esq.
FirstName LastName